Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06344143 · ClinicalTrials.gov registry record
Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma
A clinical trial of Mild Autonomous Cortisol Secretion (MACS), sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06344143 is a study of Mild Autonomous Cortisol Secretion (MACS) that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06344143, a study of Mild Autonomous Cortisol Secretion (MACS), is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the proposed study is to estimate the incidence of Mild Autonomous Cortisol Secretion (MACS) in patients with Adrenal Incidentaloma (AI) and evaluate the available diagnostic tests to determine the most sensitive and specific combination of tests for assessing MACS from adrenal adenoma for prediction of the phenotype associated with cortisol excess. As well as following the patients for 4 years and see if anything changes.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Various labs and imaging tests
Study Locations (1)
Ohio
- The Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-11-20 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06344143
The ClinicalTrials.gov registry entry for NCT06344143 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mild Autonomous Cortisol Secretion (MACS) appearing as the primary indexed condition, and to 1 intervention - of which Various labs and imaging tests is the first listed.
NCT06344143 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06344143 about?
NCT06344143 is a clinical study titled "Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma". The aim of the proposed study is to estimate the incidence of Mild Autonomous Cortisol Secretion (MACS) in patients with Adrenal Incidentaloma (AI) and evaluate the available diagnostic tests to determine the most sensitive and specific combination of tests for assessing MACS from adrenal adenoma fo...
What is the current status of trial NCT06344143?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2024-11-20. Estimated completion is 2030-12-31.
What conditions does trial NCT06344143 study?
This clinical trial studies the following conditions: Mild Autonomous Cortisol Secretion (MACS).
What interventions are being tested in trial NCT06344143?
The interventions under investigation include: Various labs and imaging tests (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06344143?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06344143 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Autonomous Cortisol Secretion (MACS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.